Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 13, 2026
Why Is Space Exploration Technologies (SPCX) Stock Down -4.22% Today?

Why Is Space Exploration Technologies (SPCX) Stock Down -4.22% Today?

Key Takeaways

  • Space Exploration Technologies (SPCX) shares fell 4.22% to $139.17 on Monday, extending a multi-session losing streak that has erased all post-IPO gains.
  • The stock now trades below its $150 debut price and is hovering just above its $135 initial public offering price from June 12.
  • A classic sell-the-news reaction following Nasdaq-100 inclusion on July 7 continues to weigh on the stock, as passive fund buying failed to offset broader selling pressure.
  • Valuation skepticism and looming insider lockup expirations are amplifying bearish sentiment, with some analysts placing fair value estimates well below current levels.
  • Traders are now focused on the company's first public earnings report, expected in early August, which could serve as the next major catalyst for the stock.

Opening Summary

Space Exploration Technologies Corp., widely known as SpaceX and trading under the ticker SPCX, saw its shares decline 4.22% on Monday to $139.17, down from the previous session's close of $145.30. The aerospace, satellite connectivity, and artificial intelligence company—which completed the largest IPO in history just over a month ago—has now surrendered roughly 38% from its post-IPO intraday peak of $225.64 reached on June 16. The decline marks the second consecutive trading day of heavy selling, pushing the stock perilously close to its $135 IPO price and deepening losses for investors who bought during the initial euphoria surrounding the record-breaking public debut.

Post-IPO Momentum Has Fully Unwound

When SPCX debuted on June 12 at $150 per share and surged to an intraday high of $225.64 within four trading sessions, it appeared the company led by Elon Musk was on an unstoppable trajectory. That momentum has now completely reversed. The stock has fallen in eight of the last ten trading sessions, with Monday's decline pushing it below the psychologically important $140 level for the first time since its opening week. The rapid unwinding reflects a market that is reassessing the premium built into shares during the initial frenzy, when limited float and intense retail interest drove prices to levels that even bullish analysts struggled to justify.

Nasdaq-100 Inclusion Triggers Sell-the-News Reaction

A key technical factor behind the recent weakness is the stock's addition to the Nasdaq-100 index on July 7. While inclusion in a major benchmark typically generates mechanical buying from index-tracking funds—JPMorgan estimated roughly $4.3 billion in passive inflows—the event instead triggered a pronounced sell-the-news reaction. Traders who had positioned ahead of the rebalance used the forced buying as an opportunity to exit positions, and once that passive demand was absorbed, selling pressure intensified. SPCX fell 6.8% on its first day in the index and has continued to slide in the sessions since, underscoring how crowded the pre-inclusion trade had become.

Valuation Concerns Dominate the Narrative

Beyond technical factors, fundamental valuation concerns are weighing heavily on the stock. At a market capitalization of approximately $1.83 trillion, SPCX trades at roughly 95 times trailing 12-month revenue of $19.3 billion—a multiple that dwarfs even the most richly valued mega-cap technology stocks. The company reported a net loss of $4.9 billion in 2025 and an accelerating loss of $4.28 billion in the first quarter of 2026, driven by heavy investment in Starship development, Starlink satellite deployment, and AI infrastructure. Morningstar recently published a fair value estimate of approximately $62 per share, while CFRA Research set a target of $115, and MoffettNathanson placed a target near $131—all well below current trading levels. Even among the 30-plus analysts covering the stock, the wide dispersion of price targets—ranging from $62 to $900—reflects deep uncertainty about how to value a company that spans three distinct and capital-intensive industries.

Insider Lockup Expirations Loom

Adding to the overhang is the approaching expiration of post-IPO lockup agreements. With only an estimated 4% to 5% of shares currently available for public trading, the limited float contributed to the stock's initial volatility to the upside. As staggered lockup periods begin to expire in the coming weeks and months, a significant wave of insider selling could hit the market. Veteran investor George Noble has publicly warned that the IPO may have been structured primarily as an exit strategy for early backers, and the prospect of increased share supply is prompting some investors to reduce exposure ahead of those events.

Competitive and Regulatory Headlines Add Pressure

Several company-specific developments have also contributed to the cautious tone. China's first successful reusable rocket booster landing in early July highlighted the growing competitive threat to SpaceX's launch dominance. Separately, the company's $25 billion bond issuance in late June—coming just weeks after the IPO raised $85.7 billion—raised questions about transparency and capital allocation. The $60 billion all-stock acquisition of AI coding startup Cursor, announced during the stock's peak, has also drawn scrutiny. Meanwhile, a public feud between Elon Musk and OpenAI CEO Sam Altman has kept the company in the news for reasons unrelated to operational performance, adding an element of headline risk.

Market Context and Trading Activity

Monday's decline in SPCX occurred against a mixed broader market backdrop, with the Nasdaq-100 index trading modestly lower. Volume in SpaceX shares was elevated relative to the 10-day average, signaling conviction behind the selling. The stock broke below its prior session low of $145.07 and tested the $137.68 level during intraday trading, establishing a new 52-week low. The move below $140 also breached the stock's opening price from its first day of trading, a technical level that traders often watch as a sentiment gauge. Unlike previous sessions where sector-wide weakness contributed to the decline, Monday's selling appeared largely company-specific, as other large-cap technology and industrial names held relatively steady.

Trending AI Robots

For traders seeking to navigate volatile markets with data-driven strategies, Tickeron offers a curated selection of AI-powered trading bots through its Trending AI Robots page. The platform hosts hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this dynamically updated section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing users to identify approaches that align with their individual goals. Whether markets are trending or choppy, the Trending AI Robots page provides a window into which automated strategies are delivering results right now.

What Comes Next for SPCX

The immediate focus for SPCX investors is the company's first quarterly earnings report as a public entity, which analysts expect in early August. The report will provide the first detailed look at revenue growth across the Space, Connectivity, and AI segments, as well as updated guidance on the timeline to profitability. The earnings release is likely to coincide with the expiration of the first tranche of insider lockup agreements, creating a potential double catalyst. Additionally, the FAA has cleared SpaceX to proceed with the next Starship test flight following a booster failure in May, and a successful launch could help restore some confidence in the company's long-term roadmap. However, with the stock still trading at extreme valuation multiples and facing both competitive and structural headwinds, the path to stabilization remains uncertain. Traders will also be watching for any updates on the company's AI infrastructure contracts with Alphabet and Anthropic, which represent a significant portion of the bull case for future revenue growth.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SPCX

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 43.01B. The market cap for tickers in the group ranges from 4.49 to 1.86T. SPCX holds the highest valuation in this group at 1.86T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 4%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 6%. DFSC experienced the highest price growth at 88%, while EVTL experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 92% and the average quarterly volume growth was 109%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 66
Price Growth Rating: 51
SMR Rating: 78
Profit Risk Rating: 71
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.